- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-09-0023214

Lakarez Pharmaceuticals Private Limited
About Lakarez Pharmaceuticals Private Limited
Data last updated:
Lakarez Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2021PTC155207.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nagarjun Reddy Nandyala and Durga Prasad Medisetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No. 3 N/Part Akash Nagar Bagh Hayathnagar, Hyderabad, Telangana, India – 501505.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.2 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.47 Lakh (net margin 0.7%) and EBITDA of ₹2.81 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Lakarez Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0023214).
Company details
Recognitions & Rankings of Lakarez Pharmaceuticals
Contact details
Lakarez Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressP.No. 3 N/Part Akash Nagar Bagh Hayathnagar, Hyderabad, Telangana, India – 501505
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lakarez Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Lakarez Pharmaceuticals Private Limited, buy the company report.
Financials of Lakarez Pharmaceuticals Private Limited
FY 2025 filings availableLakarez Pharmaceuticals Private Limited reported revenue of ₹2.2 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 96% over three years, including 36% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.81 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.47 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.3% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Lakarez Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lakarez Pharmaceuticals Private Limited
Lakarez Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagarjun Reddy Nandyala | Director | 07 Oct 2021 | 5 Years 0 Months | Current |
| Durga Prasad Medisetty | Director | 23 Sep 2021 | 5 Years 1 Months | Current |
| Naveen Kumar Bokka | Director | 23 Sep 2021 | 5 Years 1 Months | Current |
| Kunoor Anjaneyulu | Director | 23 Sep 2021 | 5 Years 1 Months | Current |
Legal cases
Lakarez Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
To see the full case history of Lakarez Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lakarez Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lakarez Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lakarez Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Nagarjun Reddy Nandyala was appointed as Director on 07 Oct 2021.
Frequently asked questions
Lakarez Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 2021 (5+ years old) and is registered under CIN U24304TG2021PTC155207.
Lakarez Pharmaceuticals has 4 current directors:
- Nagarjun Reddy Nandyala - Director
- Durga Prasad Medisetty - Director
- Naveen Kumar Bokka - Director
- Kunoor Anjaneyulu - Director
The latest financial statements of Lakarez Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Lakarez Pharmaceuticals is U24304TG2021PTC155207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lakarez Pharmaceuticals has 1 court case on record: 1 filed against it.
Lakarez Pharmaceuticals was incorporated on 23 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nagarjun Reddy Nandyala was appointed as Director on 07 Oct 2021. Durga Prasad Medisetty was appointed as Director on 23 Sep 2021. Kunoor Anjaneyulu was appointed as Director on 23 Sep 2021. Lakarez Pharmaceuticals has 4 board changes on record in total.
Yes, Lakarez Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0023214).
The registered office of Lakarez Pharmaceuticals is at P.No. 3 NPart Akash Nagar Bagh Hayathnagar, Hyderabad, Telangana, India – 501505.
Lakarez Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

